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ABSTRACT
Motivation: Personalized medicine based on molecular aspects of
diseases,suchasgeneexpressionproﬁling,hasbecomeincreasingly
popular. However, one faces multiple challenges when analyzing
clinical gene expression data; most of the well-known theoretical
issues such as high dimension of feature spaces versus few
examples, noise and missing data apply. Special care is needed
when designing classiﬁcation procedures that support personalized
diagnosis and choice of treatment. Here, we particularly focus on
classiﬁcation of interferon-β (IFNβ) treatment response in Multiple
Sclerosis (MS) patients which has attracted substantial attention
in the recent past. Half of the patients remain unaffected by IFNβ
treatment, which is still the standard. For them the treatment should
be timely ceased to mitigate the side effects.
Results: We propose constrained estimation of mixtures of hidden
Markov models as a methodology to classify patient response to
IFNβ treatment. The advantages of our approach are that it takes
the temporal nature of the data into account and its robustness
with respect to noise, missing data and mislabeled samples.
Moreover, mixture estimation enables to explore the presence of
response sub-groups of patients on the transcriptional level. We
clearly outperformed all prior approaches in terms of prediction
accuracy, raising it, for the ﬁrst time, >90%. Additionally, we were
able to identify potentially mislabeled samples and to sub-divide
the good responders into two sub-groups that exhibited different
transcriptional response programs. This is supported by recent
ﬁndings on MS pathology and therefore may raise interesting clinical
follow-up questions.
Availability: The method is implemented in the GQL framework and
is available at http://www.ghmm.org/gql. Datasets are available at
http://www.cin.ufpe.br/~igcf/MSConst
Contact: igcf@cin.ufpe.br
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
The use of gene expression proﬁling allows clinical diagnosis to
be made on a molecular level, thereby substantially increasing
diagnosis accuracy and facilitating choice of treatment based on
the patients’ genetic traits, which decisively supports the desirable
idea of personalized medicine (Spang, 2003). Moreover, identifying
disease-related genes and monitoring their activity levels provide
insights into disease mechanisms. A prominent example is cancer
∗To whom correspondence should be addressed.
wheregeneexpressionproﬁlingwassuccessfullyusedtodistinguish
between tumor and healthy cells with high accuracy and, in addition
to that, has led to the discovery of new cancer sub-types and paved
the way to personalized medicine (van’t Veer and Bernards, 2008).
Such clinical data usually have very peculiar characteristics;
while there are only few samples (patients) there are many features
(genes) (Kaminski and Bar-Joseph, 2007; Lottaz et al., 2008). Gene
expressiondataofallkindsisnotoriouslynoisyandmissingdataisa
particularly relevant issue in clinical time-series experiments, since
patientscanmisssingleexperimentsforavarietyofreasons(Irizarry
et al., 2005). Last but not least, individual patient variability is also
an issue (Irizarry et al., 2005). Overall, such clinical classiﬁcation
tasks can be considered to be among the hardest; most of the well-
known theoretical issues such as high-dimensional feature spaces,
few examples, noise and missing data apply [Kaminski and Bar-
Joseph, 2007; Lottaz et al., 2008; see Hastie et al. (2001) for
a general treatment]. As a consequence, they require the careful
development of suitable classiﬁcation methods that have to refer
to the experimental design of the clinical studies in order to make
reliable and sound predictions.
Here, we investigate the problem of classiﬁcation of Multiple
Sclerosis(MS)patientswithrespecttotheirresponsetointerferon-β
(IFNβ) treatment based on their gene expression proﬁles alone.
IFNβ can still be considered to be the standard treatment in MS.
Of the treated patients, ∼50% experience a reduced number of
relapses as well as no further increase in the disability status scale.
However, the other half of the patients do not seem to be positively
affected by IFNβ treatment. For these bad responders, treatment
should be ceased to mitigate side effects (Ro et al., 2002). To
classify and further explore clinical differences between the groups
of good and bad responders, Baranzini et al. (2005) followed 52
patients for 2 years after initiation of IFNβ therapy. Every 3 months
expressionproﬁlesof70genesweremeasuredusingone-stepkinetic
reverse-transcription PCR. Patients were divided into good and
bad responders based on clinical criteria such as relapse rate and
disabilitystatus.Theydemonstratedthatthepatients’responsecould
be predicted by studying gene expression proﬁles of the ﬁrst-time
point after treatment alone (Baranzini et al., 2005).
Since then, two supervised learning methods have been applied
to the very same dataset. Borgwardt et al. (2006) used support
vector machines, based on dynamic systems kernels. Lin et al.
(2008) based their classiﬁer on hidden Markov models (HMM)
using discriminative learning. Both of these methods proﬁted from
exploring the temporal aspects of the data. For example, a main
contribution of the HMM based method proposed by Lin et al.
(2008) was to show that patients have speciﬁc treatment response
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Fig. 1. Schematic example of the classiﬁcation problem in a 2D space in the presence of mislabeled examples and unknown sub-classes. Dark blue dots
correspond to good responders and light red dots to bad responders. With a supervised training of a classiﬁer with two HMMs (a), the mislabeled examples are
mistakenly assigned to the class indicated by the wrong label which leads to higher SD in the respective model parameters, thereby weakening the predictive
power of the model. Our approach, which uses the negative constraints (dashed lines) to guide the training (b), allows the mislabeled patients to be assigned
to the closest HMM, if the assignment improves the overall model likelihood, leading to more discriminative parameters. In other words, the soft negative
constraints resulting from wrongly labeled patients are overruled if this leads to improved overall model likelihood. Exploring the existence of sub-classes,
as in the case of three HMMs depicted in (c), can further improve class discrimination.
rates; the HMMs have the power to reveal these rates automatically,
which in turn helps to reveal the features (genes) that differ
between good and bad responders. These studies have improved
the classiﬁcation accuracy over the ones reported by Baranzini et al.
(2005), setting the current standard of ∼88% prediction accuracy.
Lin et al. (2008) also pointed out some possible methodological
ﬂaws in the classiﬁcation setup of Baranzini et al. (2005), which
resulted in overly optimistic prediction accuracy values in the
original paper. Clearly, in a clinical diagnosis problem, every
percentagepoint,reﬂectingcorrectclassiﬁcationofatleastonemore
patient, counts.
1.1 Our contributions
We propose a constrained mixture estimation method for time-series
data in order to reliably predict good and bad response to a
particular treatment. As a result, we obtain a prediction accuracy
of exceeding 90% in IFNβ treatment response classiﬁcation, which
is a substantial improvement over the previous approaches.
The idea behind clustering with constraints, which is a semi-
supervised learning method (Castelli and Cover, 1994; Chapelle
et al., 2006), is to use pair-wise constraints between patients in
order to restrict or penalize particular solutions. In the traditional
approach, these constraints can be of two types: positive constraints,
which indicate that two patients should be in the same group; and
negative constraints, which indicate that two patients should be
put into separate groups. In general, the constraints are soft, which
means that they may be violated at a certain penalty to the objective
function.
Our choice of method is motivated by two particular aspects
inherent to datasets from patient expression proﬁles. First, in
diseases with multiple molecular causes, such as MS, there could
be more than one expression signature related to a response type
of the patient (van Baarsen et al., 2006). Second, we also assume
that some patients can have a wrong label (Ro et al., 2002), or
simply that their expression signature does not match the ones of
patients with similar treatment response.Aclassiﬁcation method for
clinical purposes should indicate such patients and these samples
should not affect the estimation of the parameters needed for the
predictions.
Here, we integrate the constrained clustering method, which
was proposed by Lange et al. (2005) and Lu and Leen (2005)
into a mixture estimation classiﬁcation framework, where mixture
components are linear HMMs (Lin et al., 2008; Schliep et al.,
2003, 2004, 2005). This is done by inferring negative constraints
fromthelabelsofthepatientsandsubsequentestimationofmixtures
consisting of two or more HMM mixture components. By using
only negative constraints, the estimation method penalizes solutions
in which patients of distinct classes are assigned to the same
model, but it allows patients from a particular responder class to
be assigned to more than one model. Therefore, we can go beyond
performing binary classiﬁcation and investigate the presence of
sub-classes among the bad or good responders (Fig. 1). Also, the
constraint-based framework allows potentially mislabeled patients
to be assigned to virtually wrong classes, which mitigates their
misleading effects on the estimated parameters. Theoretically, the
idea of using constrained mixture estimation for classiﬁcation is
novel. Beyond the general advantages of mixture estimation such as
robustness and soft assignment of data points to classes, it allows to
subdivide classes, which is of particular interest here.
Furthermore, we have put special emphasis on appropriately
handling missing data and noise by extending the linear HMM
models used by Lin et al. (2008) to have mixtures of multivariate
Gaussians as state emission probability density functions (pdfs).
This appropriately accounts for the fact that Gaussian densities have
small tails. As a consequence, adding noise to single values can
easily break the mixture estimation (MacLachlan and Peel, 2000).
Our solution was to add a noise component to the emission pdfs,
as suggested by Fraley and Raftery (1998). The noise component is
also a Gaussian with mean equal to that of the whole dataset and
with a high variance.
Last but not least, we have developed a novel feature selection
criterion that is suitable for mixture estimation based classiﬁcation
tasksingeneralandsupportstheexistenceofsub-classesofpatients.
See Section 2 for more detailed descriptions.
To summarize, we classiﬁed MS patients according to IFNβ
treatment response and outperformed all prior approaches. Beyond
improving on prediction accuracy, we found evidence of sub-groups
of good responders and mislabeled patients, which raises clinical
questions that may be of particular interest. To demonstrate the
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general applicability of our method, we have also tested it on
data simulating general clinical time series including noise and
mislabeled patients.
1.2 Related work
The ﬁrst microarray analyses of the late 1990s (Eisen et al.,
1998) considered mostly static gene expression proﬁles. Since
then the ﬁeld expanded considerably. For gene expression time
courses, statistical modeling approaches, which take the temporal
interdependencies into account have proven to be superior over
approaches which do not (Bar-Joseph et al., 2002; Ernst et al., 2005;
Schliep et al., 2003, 2004, 2005). Note that Schliep et al. (2004) also
demonstrated that mixture estimation (MacLachlan and Peel, 2000)
was superior over hard assignment clustering methods in terms of
robustness and noise handling.
Semi-supervised learning was suggested as a promising approach
to proﬁt from both labeled and unlabeled data at a time (Castelli
and Cover, 1994). Most importantly, it was shown that adding only
little labeled data to the unlabeled data can decisively improve
classiﬁcation.Aﬁrst application of the idea in combination with the
expectation maximization (EM) algorithm was presented by Nigam
et al. (1999). In the meantime, the inherent classiﬁcation philosophy
has become very popular; it has been used in a variety of application
domains (Chapelle et al., 2006).
The speciﬁc idea of constraint-based (semi-)supervised learning
was presented by Basu et al. (2004) and Lange et al. (2005).
Further technical aspects were investigated by Lu and Leen (2005).
This methodology was successfully used in biological applications
to estimate mixtures of multivariate Gaussians to analyze gene
expression time-course data that was augmented with additional
information such as regulatory data (Schönhuth et al., 2006) and
expression location in Drosophila embryos (Costa et al., 2007).
2 METHODS
2.1 Notation
In the following, let
￿ t∈{1,...,T} denote the time points;
￿ k∈{1,...,K} be a running index for the mixture components
(groups/classes of patients);
￿ g∈{1,...,G} be a running index for the genes;
￿ i∈{1,...,N =N++N−} be a running index for the patients where N+
resp. N− are the numbers of good resp. bad responders; and
￿ c(i)∈{+,−} denote the class of the patient i (+ and − for good
resp. bad responders).
￿ Oi,g∈RT is the expression time course of gene g of patient i.
￿ Oi,t ∈RG is the expression of all genes at time t of patient i.
￿ Oi,g,t ∈R is the expression value of gene g of patient i at time point t.
￿ Oi∈RT×G is the collection of all expression values for patient i for all
genes g across all time points t. To summarize,
Oi=
G  
g=1
T  
t=1
Oi,g,t
⎛
⎝=
G  
g=1
Oi,g=
T  
t=1
Oi,t
⎞
⎠
￿ θ resp.   denote the parameters of a HMM with uni- resp. multivariate
emission probability densities,
￿ μ,  μ,σ,  are for uni-, multivariate means, variances, covariance
matrices referring to the uni- resp. multivariate Gaussian emission
probability densities.
O_i’s
HMM 1
HMM 2
O_i’s
HMM 2
HMM 1
O_i’s
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Fig. 2. Schematic illustration of a mixture estimation with and without
constraints. (a) The algorithm starts with an initial guess of the mixture
components. (b) After termination, the mixture optimally explains the data
points. Instead of a hard assignment to the components, each data point
has a posterior distribution over the components. (c and d) By including
constraints(dashedarrowsingreen),theEMalgorithmstrivesforanoptimum
that discriminates the negatively constrained data points.
2.2 Mixture estimation
A mixture model (MacLachlan and Peel, 2000) is deﬁned as
P(Oi| )=
K  
k=1
αkP(Oi| k). (1)
The overall model parameters  =(α1,...,αK, 1,..., K) are divided into
the prior probabilities αk,k=1,...,K, which add to unity for the model
components P(Oi| k) and the  k,k=1,...,K, which describe the density
functions that represent the components. In our case, the  k are the
parameterizations that describe the density functions of linear HMMs with
multivariateemissiondistributions,whicharediscussedbelow.Theobserved
data Oi then corresponds to the multi-dimensional time-courses that reﬂect
the gene expression proﬁles of the patients.
One now aims at maximizing (1) by choosing an optimal parameter set
 . This problem is routinely solved by the EM algorithm, which ﬁnds a local
optimum for the above function by involving a set of hidden labels Y =
{yi}N
i=1, where yi∈{1,...,K} is the component, which generates data point
Oi. For details of the EM algorithm, see Bilmes (1998).
Figure 2 (top) is a schematic illustration of a mixture estimation for two-
dimensional data. The procedure starts with the data points as well as an
initial guess   of the parameterization of the mixture. After termination of
the EM algorithm, the mixture optimally explains the data in terms of having
generatedit.Eachdatapointhasaposteriordistributionoverthecomponents
which indicates a degree of membership of the data points to the components
(orgroups).Thisformofstatisticallyconsistentsoftassignmentofpatientsto
groups has a variety of advantages, one of which is the increased robustness
w.r.t. noise. Moreover, we will exploit the posteriors for our novel feature
selection procedure (see below).
2.3 Constraints
In addition to the data, Oi one is now given a set of positive, respectively,
negative constraints w+
ij resp. w−
ij ∈[0,1], which reﬂect the degree of linking
of a pair of data points Oi,Oj,1≤i<j≤N. The task is to integrate these
constraints meaningfully and consistently into the EM routine. We will
explain the essence of the solution proposed by Lange et al. (2005). In each
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E-step of the EM algorithm, one has to compute the posterior distribution
P(Y|X, ) over the hidden labels yi, where   is an actual guess for the
parameters and X={Oi}N
i=1 is the set of (observed) data. By Bayes’rule we
have
P(Y|X, )=
1
Z
·P(X|Y, )·P(Y| ), (2)
where Z is a normalizing constant. The constraints are now incorporated by,
loosely speaking, choosing as prior distribution P(Y| ) the one, which is
most random without that the constraints and that the prior probabilities αk
in getviolated.Inotherwords,wechoosethedistribution,whichobeysthe
maximum entropy principle and is called the Gibbs distribution [see Lange
et al. (2005) and Lu and Leen (2005) for formulas and further details]:
P(Y| )=
1
Z
 
i
αyi
 
i,j
exp(−ρ+w+
ij (1−δyiyj)−ρ−w−
ij δyiyj), (3)
where Z is a normalizing constant and δ is the Kronecker delta function.
The Lagrange parameters ρ+ and ρ− deﬁne the penalty weights of positive
and negative constraints violations. This means that increasing ρ+,ρ− leads
to an estimation, which is more restrictive with respect to the constraints.
Note that computing (2) is usually infeasible and thus requires a mean ﬁeld
approximation [see again Lange et al. (2005) and Lu and Leen (2005) for
details]. Note, ﬁnally, that when there is no overlap in the annotations—more
exactly, w+
ij ∈{0,1}, w−
ij ∈{0,1}, w+
ij w−
ij =0, and ρ+=ρ−∼∞—we obtain
hard constraints as the ones used by Schliep et al. (2004).
In our case, only negative constraints were employed.To be more precise,
we set
w−
ij =
 
1 c(i) =c(j)
0 c(i)=c(j)
(4)
where c(i) denotes the responder class of patient i (in the following, we will
formally write c(i)=+resp. c(i)=−in case that patient i is a good resp. bad
responder) where both patients i,j have to belong to the training data.
Also, we set ρ−=5.0, as to make constraints to have a strong inﬂuence on
solutions. This choice was motivated by experience in previous approaches
(Costa et al., 2007).
Figure 2 (bottom) is a schematic illustration of a mixture estimation with
negativeconstraintsfor2Ddata.Asfortheordinarycasewithoutconstraints,
the procedure starts with the data points as well as an initial guess   of the
mixture. However, the negative constraints drive the algorithm to look for an
optimal solution that discriminates between the negatively constrained data
points.
2.4 Linear HMMs, noise and missing data
An HMM is a probabilistic model composed of a Markov chain with M
discrete states and emission pdfs assigned to each state. At a given time
point, an HMM is at a particular unknown state and it emits a symbol in
accordance to the density function assigned to that state. In particular, we
are interested in linear HMMs that follow a linear chain topology, i.e. hidden
states are linearly ordered and there are only self-transitions or a transition
to the next state. For example, in the HMM depicted in Figure 3—with three
emitting states—the ﬁrst one with a mean emission of zero and the second
one with a mean emission of one and the third around zero, we model time
courses displaying an upregulation pattern. Such models have already been
applied in a variety of previous gene expression time course studies and
described in detail (Schliep et al., 2003, 2004, 2005, Lin et al. 2008).
More formally, an HMM is parameterized by a transition matrix A=
{aml}M×M, where aml is the probability of going from state m to l.A sw e
restrict the topology to a linear chain of states, we only need to deﬁne the
self-transition probability amm for a given state m,a sam(m+1)=1−amm and
all other transitions from state m are set to zero. We also have an initial
probability vector  , where πm is the probability of starting at state m,
which in the linear HMM is π1=1 and 0 otherwise.
Finally, we have an emission function for each state for which we use
mixtures of multivariate Gaussians. They consist of three components:
component one is a multivariate Gaussian with diagonal covariance matrices
Fig. 3. Example of an HMM with three hidden states modeling time courses
with an upregulation pattern. Above each state, the emission densities for
the univariate case, light grey corresponds to the expression emission with
parameters μm and σm and dark gray to the noise component.
modeling patient expression values as in Lin et al. (2008), component two—
thenoisecomponent—isamultivariateGaussianwithmeansequaltothedata
center and a broad covariance matrix responsible for modeling observations
due to noise (Fraley and Raftery, 1998). The third component ﬁnally is for
handlingmissingdata.Therefore,wedeﬁneaspecialsymbolNanandextend
thevariablespaceforOi,t fromRG toRG∪{Nan}.IfthevaluesOi,t ofpatient
i at time point t are missing, we set Oi,t :=Nan.As a density function Pk
m for
emitting a (multivariate) expression value Oi,t from state m of the kth HMM
 k we obtain
Pk
m(Oi,t) = (1−φmiss−φnoise)·N(Oi,t|  μk
i , k
i )
+φnoise·N(Oi,t|  μnoise, noise)
+φmiss·δ(Oi,t,Nan),
where   μk
i and  k
i denote the mean values and diagonal covariance matrices
of the G-dimensional expression vectors, φmiss is the proportion of missing
observations in the data and φnoise the proportion of noise observations. For
the noise component,   μnoise is a vector containing the average expression
values of the genes across all patients and time points and  noise has
diagonal entries set to a high value, e.g. σgg=5.00, and all other entries
are set to 0. In the experiments, we set φmiss to be equal to the proportion
of missing observations in the real data and φnoise=0.05.
In summary, each linear HMM  k corresponds to the parameterization
 k =(Ak,Bk, k),
where
Bk =(  μk
1,...,  μk
M, k
1,..., k
M,  μnoise, noise,φnoise,φmiss)
are the emission parameters. We can then apply the Baum–Welch
algorithm for estimating the parameters of the HMMs for a given
assignment of patients derived from the mixture estimation. The parameters
  μnoise, noise,φnoise,φmiss are kept ﬁxed in the estimation. We refer
the reader to Bilmes (1998) for a detailed description of the Baum-Welch
algorithm.
2.5 Core Classiﬁcation Algorithm
Assume that one is given both {+,−}-labeled (training) and unlabeled (test)
data, where the aim is to infer labels for the unlabeled data. Based on the idea
of constrained mixture estimation, we employed the following algorithmic
procedure:
(1) Estimate a constrained mixture, in the supervised case only using
training data (HMMConst) and using all data in the semi-supervised
case (HMMConstAll). In both cases, constraints are available only
for the training data.
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(2) Assign each of the mixture components to one of the classes +,− by
determining to what degree, in terms of their posteriors, the labeled
data points contribute to it.
(3) Assign the unlabeled data to the components by determining the
maximum entry in their posterior distribution. In the semi-supervised
case,posteriorsarereadilyavailable.Inthesupervisedcase,posteriors
have to be computed upon termination of the mixture estimation
procedure. This way, the class labels of the components determine
the labels of the datapoints.
2.6 Feature selection
As feature selection in mixture estimation-based classiﬁcation has not been
presented elsewhere as of yet, we will go into a little more detail.
After application of the semi-supervised procedure, we remain with a
mixture of multivariate HMMs such that the likelihood of the multivariate
time course of patient i w.r.t. that mixture is computed as
P(Oi| )=
K  
k=1
αkP(Oi| k), (5)
where   comprises all parameters of all HMMs  k with multivariate
emissionstogetherwiththepriorsαk ofthecomponents k.Inordertoselect
features (genes) g that help classify the data best, we apply the following
algorithm:
(1) For each gene g deﬁne new HMM components θk,g with univariate
emissions by adopting the topology of  k for all θk,g. That is, we set
a
k,g
ij :=ak
ij, (6)
which means that the transition probabilities α
k,g
ij of changing from
state i to state j in model component θk,g is just ak
ij, the equivalent
transition probability in the multivariate  k. Furthermore,
μ
k,g
i :=(  μk
i )g (7)
that is, we deﬁne the means of the Gaussian emission pdfs of θk,g to
be those of the dimension of the multivariate   μk referring to gene g.
Likewise,
σ
k,g
i :=( k
i )gg, (8)
where ( k
i )gg is the main diagonal entry of  k
i at row resp. column
referring to gene g. Overall, the θk,g can be perceived as ‘univariate
copies’ofthemultivariate k,wherethereisonecopyforeachgeneg.
(2) For each gene g, we compute ‘positive’ priors α+
gk (for the good
responders) as well as ‘negative’ priors α−
gk (for the bad responders).
Therefore, we assume that the mixture
P(Oi,g| g)=
K  
k=1
αkP(Oi,g|θk,g) (9)
has generated all time courses Oi,g of gene g of the patients i where αk
isjusttheprioroftheestimatedmultivariatemixture(5).Computation
of ‘positive’ and ‘negative’, gene-speciﬁc priors α+
gk and α−
gk then
is done by adopting the usual procedure of the EM algorithm. In
more detail, let  g=(α1,...,αK,θ1,g,...,θK,g) be the entirety of the
parameters that describe the univariate mixture (9) for gene g.W e
deﬁne
α+
gk :=
1
N+
 
i,c(i)=+
P(ygi=k| g,Oi,g) (10)
α−
gk :=
1
N−
 
i,c(i)=−
P(ygi=k| g,Oi,g)( 1 1 )
where ygi is the (hidden) variable that speciﬁes which component has
generated time course Oi,g and
P(ygi=k| g,Oi,g)=
αkP(Ok,g|θk,g)
 K
k =1αk P(Oi,g|θk ,g)
. (12)
(3) For each gene g, compare the positive prior distribution
(α+
g1,...,α+
gK) (13)
with the negative prior distribution
(α−
g1,...,α−
gK). (14)
Note ﬁrst that one has declared the multivariate components  k in (5)
to be either positive or negative ones. If the sum of the positive
priors,runningoverthenegativecomponentsk isgreaterthanthesum
over the positive components, or vice versa, the sum of the negative
priors is greater over the positive components, discard gene g.I f
not, compute the Kullback–Leibler divergence of the positive prior
distribution and the negative prior distribution. The greater it is,
the better the gene discriminates. Rank the genes accordingly and
choose an appropriate cut-off. Select the genes above the cut-off as
appropriate features.
(4) Recompute a multivariate mixture using only the selected genes
according to the procedure in Subsection 2.5 to perform class
prediction.
2.7 Clustering consensus
InanalogytotheclassiﬁcationproceduresadoptedbyBaranzinietal.(2005),
Borgwardt et al. (2006), and Lin et al. (2008), we performed classiﬁcations
of the patients for several re-samples of the dataset. In detail, we performed
20 classiﬁcations from a ﬁve-replications 4-fold scheme. As a consequence,
we need a procedure that combines the possibly different classiﬁcations into
one single classiﬁcation of each patient. Such an analysis is also important
from two aspects: it will indicate if candidate (sub-)groups of patients are
stable, i.e. if they reappear in the same (sub-)class in many solutions. Also,
it indicates if particular patients are consistently grouped with patients of
distinct labels, and/or if patients are potentially mislabeled.
For this task, we use a procedure described by Monti et al. (2003) and
Brunet et al. (2004). First, we build a co-clustering matrix by counting for
each pair of patients the number of times they appear in the same group
acrossthedifferentsolutions.Thismatrixisusedasasimilaritymeasurefora
subsequent hierarchical clustering procedure where the rows and columns of
the matrix are reordered such that patients with similar co-clustering patterns
become neighbors. Finally, the resulting dendrogram is cut as to return the
same number of groups as in the individual solutions.An example of such a
matrix can be seen in Figure 5, where red squares represent pairs of patients
in the same group at several solutions, while blue squares represent pairs not
in the same group in the same solutions. Red squares indicate stable groups
shared over several solutions.
2.8 Datasets
2.8.1 Simulated dataset We resort to simulated data for a general analysis
of the performance of the currently available methods on data with
the speciﬁc characteristics of clinical time series. As a basis for such
a comparative analysis, we use the simulated data that was proposed
by Lin et al. (2008). It consists of 100 patients divided into two classes of
50 patients each. Each patient has 100 genes with 8 time points. Out of the
100 genes, only 10 had expression patterns which are substantially different
between the two patient groups. The corresponding genes should preferably
be chosen by feature selection subroutines. The generation mechanism
behind the simulated data is to sample time series from a piecewise linear
function. At a later step, patient-speciﬁc response rate is included by
shrinking and expanding the curves. However, noise in form of outliers and
mislabeled data had not been taken into account.
To take these issues into account, we expanded the previous analysis
by (i) including outlier values at individual time points of a gene and (ii)
including mislabeled time series.This way, we can compare the performance
ofthemethodsw.r.t.thesetwocharacteristics,whichareubiquitousinclinical
studies on gene expression. For the ﬁrst procedure, we select combinations
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of genes and time points according to a probability pγ. When a gene time
pointhadbeenselected,weaddedtoitavaluesampledfromanormaldensity
function N(1,1). We generate ﬁve such datasets by varying pγ from 0.01 to
0.05. Mislabeling was simulated by changing the labels c(i)o fl patients. We
generated four datasets by setting l f r o m1t o4 .
2.8.2 MS treatment response data Blood samples enriched with
mononuclear cells from 52 relapsing-remitting MS patients were obtained 0,
3, 6 , 9, 12, 18 and 24 months after initiation of IFNβ therapy, which resulted
on an average seven measurements across the 2 years (Baranzini et al.,
2005). Expression proﬁles were obtained using one-step kinetic reverse-
transcription PCR over 70 genes selected by the specialists to be potentially
related to IFNβ treatment. Overall, 8% of measurements were missing due
to patients missing the appointments. We applied a log transformation in the
expression values.
After the 2 year endpoint, patients were classiﬁed as either good or bad
responders,dependingonstrictclinicalcriteria.Badrespondersweredeﬁned
as having suffered two or more relapses or having a conﬁrmed increase of
at least one point on the expanded disability status scale (EDSS). In short, a
good responder was to have a total suppression of relapses and not allowed
to have an increase on the EDSS. From the 52 patients, 33 were classiﬁed as
good and 19 as bad responders. Note, however, that the reliability of these
criteria has not been conclusively settled (Ro et al., 2002).
3 DISCUSSION
For both simulated and real data, we analyzed the classiﬁcation
accuracy of the HMM mixtures resulting from the constrained
estimation procedure where mixtures consisted of 2, 3 or 4 groups
and were estimated from the labeled data alone, reﬂecting a
supervised learning scenario (HMMConst). We compared it with
the generative HMM classiﬁer (HMMClass) and discriminative
HMM classiﬁer (HMMDisc), both from Lin et al. (2008). We also
included IBIS (Baranzini et al., 2005) and Kalman Filter
SVM (Borgwardt et al., 2006) in the comparison. For constrained
estimation of mixtures of HMMs, we also investigated the use
of unlabeled patients during training (HMMConstAll). This case
reﬂects a semi-supervised scenario, where, in contrast to the purely
supervised case, estimation and classiﬁcation are merged into
one step by integrating the unlabeled data into the estimation
procedure. Note that semi-supervised learning reﬂects a perfectly
realistic classiﬁcation scenario; no assumptions about the unlabeled
data are made. For each particular method, a ﬁve replications 4-
fold procedure is applied, as performed in previous approaches
(Baranzini et al., 2005; Borgwardt et al., 2006; Lin et al., 2008).
Training accuracies are used to select the number of features
and to choose the optimal number of groups. For sake of fair
comparison, we used HMMs with three states for simulated
datasets and four states for real datasets, just as suggested by
Lin et al. (2008). Comparison of the methods, as usual, then is
based on the prediction accuracy achieved on the test sets. The
method is available at http://www.ghmm.org/gql and data sets at
http://www.cin.ufpe.br/~igcf/MSConst.
3.1 Simulated data
One of the aspects we analyzed is the beneﬁt of adding the noise
component, as described in subsection 2.4, into the generative
classiﬁer HMMs. As can be seen in Figure 4a, for HMMClass
without the noise component, the accuracy deteriorates from around
90–85%, in case of adding noise to 5% of the time points. When
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Fig. 4. Accuracy on simulated data (a) after addition of noise to x% of time
points and (b) after inclusion of wrong labels.
Table 1. Classiﬁcation accuracy of distinct methods in the MS patient
response data
Method Number of genes Training Test
Accuracy (%) Accuracy (%)
IBIS 3 – 74.20
HMMClass 70 87.15 76.52 (+/− 0.03)
HMMConst4 35 89.62 78.08 (+/− 17.0)
HMMConst2 70 87.12 80.49 (+/− 9.5)
HMMConst3 70 88.26 81.38 (+/− 10.0)
HMMDisc 7 – 85.00
Kalman SVM – – 87.80
HMMClass 17 93.66 89.34 (+/− 8.5)
HMMConst2 17 92.31 89.62 (+/− 8.1)
HMMConst3 17 92.60 90.39 (+/− 7.2)
HMMConstAll3 17 93.64 92.31 (+/− 7.6)
HMMConstAll2 17 93.47 92.70 (+/− 6.1)
employing a noise component, the accuracy of HMMClass stays at
around 90%. A t-test conﬁrms signiﬁcance of the higher accuracy
of HMMClass with a noise component when >1% of noise is added
(P-value > 0.05). As shown before, with the noise component the
emission distributions have longer tails (Fraley and Raftery, 1998)
which makes the model estimation more robust to outlier points.
The second aspect we analyzed was the inclusion of wrong
labels into the patient response data. In this scenario, we compared
the performance of the classiﬁers with generative HMMs and
constrained mixture estimation with HMMs. As can be seen in
Figure 4, the accuracy of both methods deteriorates with the
inclusion of random labels. However, HMMConst has an overall
better accuracy than HMMClass. Indeed, HMMConst assigned
92% of the mislabeled examples to their original class. This agreed
with our intuition that the constrained mixture estimation can take
care of mislabeled data points, which corresponds to the situation of
constraints being overruled by the location of the data points which
yields more discriminative models.
3.2 Classiﬁcation of MS treatment response
In Table 1, we have displayed the training and test classiﬁcation
accuracy on the MS data. Overall, both semi- and purely supervised
versions of HMMConst with two and three mixture components
have the best classiﬁcation performance among the competing
classiﬁers. Accuracies of HMMConstAll2, HMMConstAll3,
HMMConst3 with feature selection are higher than IBIS,
HMMDisc, Kalman SVM (t-tests indicate P-value < 0.05) and
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accuracy of HMMConst2 with feature selection is higher than
IBIS and HMMDisc (t-tests indicate P-value < 0.05). On the
other hand, HMMConst4 has a very poor performance, which
indicates that there is no support for four different responder
groups in the data. Also, all methods based on all 70 genes
(HMMClass, HMMConst2, HMMConst3) had a poor performance,
which reinforces the importance of feature selection. Note that there
is no clear statistical distinction between the accuracies resulting
from using two or three mixture components in both HMMConst
and HMMConstAll. However, we will put particular emphasis on
the results with three groups in the next sections, as it reﬂects
the existence of sub-groups of MS patients, which has recently
been conﬁrmed in the MS literature. Note also that HMMClass is
higher than the closely related discriminative classiﬁer proposed by
Lin et al. (2008). While results from Lin et al. (2008) show that
both methods are similar, the superior classiﬁcation performance
displayed here results from the employment of the noise component,
as discussed above, in our implementation.
Overall, the HMMConstAll2 and three groups achieve the best
classiﬁcation performance. As this is due to the integration of
the unlabeled observations (Chapelle et al., 2006) this indicates
superiority of semi-supervised over purely supervised classiﬁers.
Indeed, for the small study we analyze here semi-supervised
approaches are expected to deliver particularly favorable results
from purely theoretical considerations. Note, that employing our
method within a purely supervised setting also performs best when
compared to purely supervised approaches.
3.2.1 Selected genes A particularly interesting aspect from a
biological point of view is to compare the sets of genes selected as
classiﬁcation features by the different methods. Overall, our method
preferred greater numbers of genes as features (17 genes in most
cases) than the HMM Discriminative learning proposed by Lin et al.
(2008),whichselectsevengenes:Caspase2,Caspase3,Caspase10,
IL-4Ra, Jak2, MAP3K1, RAIDD. Out of these, only RAIDD is
not present in the genes selected by our method (see Fig. 7 and
Supplementary Material for the list of genes). When comparing our
sets of genes to the 12 genes selected by Baranzini et al. (2005),
we ﬁnd that eight genes are shared by our method HMMConst
(Caspase 2, Caspase 3, Caspase 10, IL-4Ra, IRF2, IRF4, STAT4,
MAP3K1). Our approach also identiﬁes some genes that are not
indicated by others. Out of those, we stress two proteins with high-
discriminative scores: Tyk2, which is part of the Jak-Stat pathway
and related interferon signaling (Yang et al., 2005), and BAX, which
is a known apoptosis regulator. While it is hard to evaluate, the sets
of selected genes, as being highly overlapping with those of the
previous studies, it is clear that the genes exclusively identiﬁed as
classiﬁcationfeaturesbyourmethodhelpedusdecisivelytoincrease
the prediction accuracy.
3.3 Constraint based mixture estimation: sub-classes of
patient responders
To inspect the existence of stable sub-classes of patient
responders, we performed the consensus analysis in the results of
HMMConstAll3. As can be seen in Figure 5, the matrix reveals
two big blocks, one in the upper left corner, referring mainly to bad
responders;andanotheroneinthelowerrightcorner,consistingonly
of good responders. Furthermore, the consensus method indicates
Fig. 5. Matrix depicting the co-clustering of patients for HMMConst with
three groups. A particular position in the matrix represents proportion of
times the pair of patients was in the same group; red values indicating higher
values. Red squares indicate stable groups of patients that tend to be grouped
in several solutions. The bars above the matrix indicate the groups found by
HMMConst (red for bad responders, dark blue for good responders 1 and
light blue for good responders 2); and the classiﬁcation of patient response
based on clinical criteria only. The arrow indicates the putative mislabeled
patient.
that the class of good responders is formed by two sub-classes:
good responders 1 and good responders 2 (indicated by dark blue
and light blue bars on the top).
Theconsensusmatrixalsoindicatesonepatient(1126381)which
is labeled as a good responder, but grouped together with the bad
responders(thesamepatientisalsomisclassiﬁedintheHMMConst2
as indicated in the Supplementary Material). A closer inspection of
the criteria used to deﬁne the patient response revealed that patient
1126381 was likely misclassiﬁed in the original study (Baranzini
et al., 2005). One of their criteria to classify a patient as bad
responder was an increase by one in the EDSS over the 2 years of
treatment.According to the data present in Supplementary Material,
patient 1126381 had a change in EDSS = 1, which just meets one of
the criteria to classify a patient as a bad responder. This mislabeled
example was later conﬁrmed by the author of the original study
(S.E. Baranzini, personal communication).
The existence of two sub-classes of good responders is further
supported by the average time-series proﬁles and their alignments
to the respective HMMs. In Figure 6, we display the average
expression proﬁles of the genes in the three groups of patients
found: bad responders (red), good responders 1 (dark blue) and
good responders 2 (light blue). Final list of genes are obtained by
ranking all features selected during training, summing their rank
values and selection the top genes. In the ﬁgure, genes order reﬂect
their relevance.
For some genes, both sub-classes of good responders exhibit
similar proﬁles (Caspase 10, MAP3K1, STAT4, IFN-gRB, IRF8,
IRF5, IRF2, Caspase 5 and IFNaR2). Interestingly, for some genes
(Tyk2, Jak2, IFNaR2, ILR-2rg), bad responders had the highest
expression whereas the good responders 1 had lowest expression
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and good responders 2 had expression values between those groups,
while for other genes (Caspase 3, BAX, IL-4Ra and IRF4),
the expression proﬁles of bad responders and good responders 2
are similar and display higher expression values than the good
responders 1. KEGG pathway (Kyoto Encyclopedia of Genes and
Genomes) enrichment analysis, which was performed with the tool
GOST (Reimand et al., 2007), indicates that genes in the ﬁrst two
groups are related to Jak-Stat pathway, while genes in the last group
areinvolvedintheapoptosispathway.Oneparticulargene,Caspase2
has an overexpression pattern for good responders 2, while good
responders 1 and bad responders both had a lower, but similar
expression values. These proﬁles indicate that patients belonging
to the sub-class of good responders 2 share some expression marker
characteristics with good responders in general, but also some
marker characteristics of bad responders.
An example of a gene of potentially particular interest that
is differentially expressed between the two sub-types of good
responders is IL-4Ra, which is involved in the regulation of
B-cell mediated immune response (Nelms et al., 1999). Note
that there has been a recent debate on the role of B cells
in MS and the deﬁnition of disease subtypes based on the
individual types of antibodies acting as key players in the disease
(Archelos et al., 2000).
4 CONCLUSION
We have presented a statistically sound and reliable methodology
for analysis and classiﬁcation of clinical time series. It is based on
the novel idea of employing constraint-based mixture estimation to
perform semi- and purely supervised clinical classiﬁcation tasks.
As a result, we outperformed all prior approaches w.r.t. prediction
accuracy on both simulated and MS treatment response data.
Moreover, we found that classiﬁcation of treatment response
data was best when subdividing the positive responders into two
subclasses, which might raise some interesting clinical questions
to be pursued further. This also coincides with recent ﬁndings
on MS pathology (Satoh et al., 2006; van Baarsen et al., 2006),
which indicated that MS patients display distinct expression proﬁles
signatures.
Furthermore, we found out after submission that one of the
patients that we putatively misclassiﬁed was originally mislabeled
(S.E.Baranzini,personalcommunication).Consequently,prediction
accuracy increases by 2% for all methods; 95% of accuracy from
HMMConst3 and 90% of the Kalman Filter SVM. This would
not only mean that we have been able to decrease the relative
error rate by 50%, but also that we come close to perform accurate
personalmedicinediagnosiswhenevaluatingIFNβ treatmentinMS
patients.
A general explanation for the superiority of our approach is its
capacity of handling of noisy, missing data and mislabeled patients.
This could be conﬁrmed by, respectively, designed experiments on
simulated data. It has been widely noted that mixture estimation is
more robust when it comes to processing noisy and incomplete data
(e.g. Schliep et al., 2005). Last but not least, note that the idea of
employing mixture estimation for classiﬁcation tasks allowed us to
ﬂexiblyperformsub-classiﬁcation,whichwasofparticularusehere.
We would like to point out that, beyond the speciﬁc usage of our
method outlined here, it could be applied in classiﬁcations task on
other diseases with multiple genetic causes, such as cancer (van’t
Veer and Bernards, 2008).
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